As a Swiss pharmaceutical manufacturer, Acino can look back on to a long history in producing oral soild dosage forms for all major generic companies at the highest quality possible and has developed profound and special know-how within this field. Especially for products that are hard to make, Acino has a well-known track record:
However, Acino understands well the needs of their customers, e.g. price sensitivity. In combination with our packaging site in Estonia, which is also capable to produce smaller lot sizes, Acino provides a cost competitive production with EU batch release.
Last but not least, Acino is always thriving to achieve the highest customer satisfaction and our professional and experienced technical and commercial teams will always give their greatest commitment to make the impossible possible for our customers
Adare Pharma Solutions is a global technology-driven specialty CDMO providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare’s technology platforms specialize in ODT, taste masking and customized drug release.
Fresenius Kabi Contract Manufacturing is a global leader in the contract development and filling & finishing of sterile pharmaceuticals as well as for the development and supply of medical devices. Being part of Fresenius Kabi, we offer our customers access to the expertise of more than 20 Manufacturing and Research & Development Facilities worldwide.
Unparalleled production capabilities, outstanding quality compliance, and an excellent track record in contract manufacturing have made Fresenius Kabi Contract Manufacturing the supplier of choice of an impressive number of pharmaceutical companies.
The integral concept of combining development and production for sterile medicinal products and develop additionally the respective medical devices for your application makes us a one-stop-shop for nearly every kind of project.
Please get in touch at email@example.com
PCI Pharma Services is an integrated full service provider, a proven and trusted partner to leading companies in the global healthcare industry. We offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialization, delivering speed-to-market and commercial success for our customers. Our core services support each stage of the product lifecycle, including drug development, clinical trial supply, manufacturing, commercial launch and ongoing commercial supply. We partner with clients in providing innovative technologies, flexible solutions, and an integrated supply network supporting lifesaving medicines destined to over 100 countries around the world.
Follow us on Twitter at @pci_social
Pfizer CentreOne® is a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Our global manufacturing network includes more than 35 sites across six continents. Backed by Pfizer resources, we deliver technical expertise, global regulatory support and long-term supply. For more than 40 years, we've been guiding complex compounds securely and efficiently from development through commercial manufacture.
Find out more about their services:
Skyland Analytics helps life science innovators and manufacturers producing clinical- and commercial-phase products more efficiently collect, analyze, report, and share process data across internal and external teams, sites and partners by offering cloud-based software - Skyland PIMS® - that ensures Part 11-compliant data transparency and integrity.
A growing number of customers use PIMS to move off excel into a centralized, compliant data repository; create better visibility into batch data across your supply chain; accelerate regulatory reporting (CPV, APR, CMC); expedite scale up, tech transfer and commercial release; and establish a low-cost digital IT infrastructure.
The Siegfried Group is a global life sciences company with sites in Switzerland, the USA, Malta, China, Germany, France and Spain. In 2019, the company achieved sales of 833.5 million Swiss francs and currently employs about 3500 people at eleven sites on three continents.
Siegfried Holding AG is publicly listed on SIX Swiss Exchange (SIX: SFZN). Siegfried is active in manufacturing pharmaceutical APIs (and their intermediates) as well as drug products (tablets, capsules, sterile vials, ampoules, and cartridges) for the pharmaceutical industry and provides development services.